OR WAIT null SECS
November 25, 2014
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
Thermo Fisher Scientific announced a collaboration with Samsung to design, develop, and market new solutions for point-of-care.
November 24, 2014
An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.
GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.
November 17, 2014
Spanish-based healthcare company, Grifols, announced that FDA approved the expansion of the plasma fractionation unit at its Clayton, North Carolina facility.
November 12, 2014
GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.
November 06, 2014
The deal between the two companies will strengthen Perrigo's presence in Europe.
November 04, 2014
Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.
October 20, 2014
AbbVie to pay Shire $1.635 billion break fee for terminating purchase agreement.